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The developmental changes in glutamine synthetase activity in rat liver and brain 
have been studied and shown to be different in the two tissues. The liver enzyme ex- 
hibited a fall in activity after birth, followed by a slow recovery and a rapid increase 
in activity for a short interval of time, before a gradual rise to the adult level in about 
40 days. The brain enzyme raised its activity gradually and steadily right after birth 
until it reached the adult level in about 18 days. 
The enzyme activity in the liver of developing rats appears to be affected by those 
compounds that also affect protein synthesis, ribonucleic acid synthesis, or deoxyribo- 
nucleic acid synthesis. When injected into young rats, puromyein, nL-p-fluorophenyl- 
alanine, ammonium lactate, actinomycin D, and 8-aeaguanine lowered the enzyme 
activity in liver, whereas nL-ethionine, cortisol, L-thyroxine, and 5-fluorouracil ele- 
vated it. The absence of effect of these compounds on the enzyme activity in vitro sug- 
gests that the changes observed may result from their effect on the amount of the 
enzyme formed in the liver. In most instances, the enzyme in the brain escaped the 
effect of these compounds. 
With repeated injections of puromycin to block the synthesis of glutamine synthe- 
tase, the enzyme in the liver and testis, respectively, lost one half of its original activ- 
ity in about 14 hours and 7.5 hours. A very slight decrease in the activity, however, 
occurred in the brain and kidney. 
INTRODUCTION 
The prenatal development of glutamyl 
transferase, an enzyme closely related to 
glutamine synthetase, has been studied in 
the chick embryo (2)) and in the brain of the 
fetal pig and monkey (3). But the change in 
glutamine synthetase activity following 
birth of an animal has not been reported. 
The postnatal change in an enzyme activity 
in an animal may belong to one of the 
following patterns: (a) The enzyme activity 
is not detectable or very low at birth, but 
increases to the adult level very rapidly, 
such as tryptophan peroxidase in guinea 
pig liver (4). (b) The enzyme activity is 
negligible at birth, but reaches the adult 
1 Paper II of this series described the intracellu- 
lar localization of glutamine synthetase in rat 
liver (1). 
level only gradually, such as Shydroxy- 
tryptophan decarboxylase in rat kidney (5). 
(c) The enzyme activity at birth attains or 
exceeds the adult level, such as tyrosine 
transaminase in rat liver (6). (d) The en- 
zyme activity decreases following birth and 
then gradually increases to the adult level, 
such as glucose 6-phosphate dehydrogenase 
in rat liver (7). The pattern of change for a 
given enzyme may also depend on the 
species of the animal studied (8). 
The pattern of change with age in gluta- 
mine synthetase activity in rat liver is 
similar to (d) above, whereas that in rat 
brain resembles (b). In addition, compounds 
producing different metabolic effects have 
been injected into the developing rat in an 
effort to understand the mechanisms by 
which the enzyme activity may be con- 
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trolled. This paper describes these observa- 
tions. 
EXPERIMENTAL PROCEDURE 
Rats of the Sprague-Dawley strain from several 
hours t,o GO days of age were used. Infant rats of 
the same age but from different litters could have 
significantly different liver glutamine synthetase 
activities, although the enzyme activity varied 
relatively little among litter mates. Hence, rats 
from different litters served to obtain the mean 
value for the enzyme activity in a particular age 
group, so that the value obtained would be more 
representative. Both the lactating and the wean- 
ling rats received a laboratory chow. In the experi- 
ments where the in vivo effect of various eom- 
pounds on the enzyme activity was studied, litter 
mates always served as the control in each experi- 
ment. Most of the compounds tested were prepared 
in physiological saline, with pH adjusted to 7.2, 
and injected intraperitoneally, except cortisol 
which was dissolved in sesame oil and given intra- 
muscularly. Single daily injections of a test com- 
pound began when the animals reached 15 days of 
age and continued for 3 consecutive days. The 
controls received saline or sesame oil as the case 
may be. The animaIs were killed one day after the 
last injection. Deviations from this general plan 
occurred in a few instances; they will be noted. 
In another series of experiments, puromycin 
dihydrochloride (Nutritional Biochemicals Cor- 
poration) was injected repeatedly into 24-day-old 
male rats to study the rates of breakdown of gluta- 
mine synthetase in different organs. These animals 
were killed from one to 7 hours following the initial 
injections of puromycin. 
Clutamine synthetase activity and glutamine 
in the tissue homogenates were determined as 
before (9). One unit of the enzyme activity is de- 
fined as the amount of enzyme that will synthesize 
one micromole of r-glutamyl hydroxamic acid in 
one hour at 37°C. The method of Lowry et al. (10) 
served for determining the protein, with cry&,- 




Figure 1 shows the change in glutamine 
synthetase activity in liver of rats during 
the first 60 days of life. The enzyme activity 
has been expressed in four different ways, 
namely, units per milligram of protein 
(specific activity), units per gram of liver 
(tissue activity), units per liver (total ac- 
FIG. 1. The change in glutamine synthetase 
activity in liver of rats during the first 60 days of 
life. The enzyme activity, shown on the ordinate 
on a logarithmic scale, is expressed as units per 
milligram of protein (a), units per gram of tissue 
(O), units per tissue (X), and units per tissue per 
100 gm of body weight (A). The concentration of 
free glutamine (0) is expressed in terms of micro- 
moles per gram of tissue. Each point represents the 
average from 3 to 8 rats. 
tivity), and units per liver per 100 grams of 
body weight, to take into account the rapidly 
increasing protein content of the tissue, 
tissue weight, and body weight during the 
period of observation. Since rats constituting 
a given age group came from different lit- 
ters, the variation would be expected to be 
wider than if they had come from a single 
litter. The average deviation from the mean 
for the enzyme activity, expressed in any 
of the four ways, varied from 5 to 15% of 
the mean value. We can see that, in the 
liver, the enzyme activity showed a de- 
crease soon after birth and reached its 
lowest point in about 3 days. The liver did 
not recover its neonatal loss of the enzyme 
activity until the fourteenth day after birth. 
The recovery during this period appeared 
to be a slow process. Once the enzyme had 
regained its activity at birth, however, a 
rapid increase ensued between the fourteenth 
and the eighteenth days of life. After that, 
the enzyme activity gradually reached its 
adult level on about the 40th day. These 
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observations show that the postnatal change 
in glutamine synthetase activity in rat liver 
undergoes four stages in the following order: 
an initial fall, a slow recovery, a rapid 
increase, and a gradual rise to a plateau. 
Efforts have been made to understand 
the initial fall of the enzyme activity. 
Combining the liver homogenate from 3-day- 
old rats with that from 21-day-old rats 
always yielded an activity equal to the 
summed activities of the two homogenates, 
indicating that the lowering of the enzyme 
activity in the liver of 3-day-old rats was 
not due to an inhibitor. Prior incubation of 
the whole blood or serum from pregnant 
rats with the liver homogenate from 3-day- 
old rats at room temperature for 3 hours 
failed to raise the enzyme activity of the 
homogenate. The last observation appears 
to suggest that the loss of the enzyme 
activity in the 3-day-old rat may not result 
from the lack of a humoral factor in the 
maternal blood circulation. 
The developmental change in the en- 
zyme activity in brain (cerebrum), shown in 
Fig. 2, differed from that in liver in three 
aspects: (a) No initial loss of the enzyme 
activity occurred after birth. (b) The in- 
crease in the enzyme activity proceeded at 
a steady rate until the adult level was 
reached. (c) The enzyme in brain attained 
its adult level in 18 days after birth, in 
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FIG. 2. The change in glutamine synthetase 
activity in brain of rats during the first 60 days of 
life. For explanation of symbols, see Fig. 1. 
contrast to the enzyme in liver which took 
about 40 days. These observations show a 
definite difference in the developmental 
change in the activity of one enzyme be- 
tween two organs of the same animal. 
Free glutamine in liver and brain has been 
determined also. The average deviation 
from the mean amounted to about 10% of 
the mean value for each age group. Com- 
parisons of the concentration of free gluta- 
mine (Figs. 1 and 2) with glutamine syn- 
thetase activity in the same tissue show 
that the changes with age in these two 
parameters bore some correlation in the liver, 
but not in the brain. 
The curves for specific activity, tissue 
activity, and total activity per 100 gm of 
body weight exhibited a similar shape up 
to 40 days of age for liver and 18 days of 
age for brain. After that, the total activity 
per 100 gm of body weight dropped in both 
tissues, showing a diminishing ratio of tissue 
weight to body weight. 
RESPONSIVENESS TO METABOLIC 
ALTERATIONS 
Compounds with different metabolic func- 
tions have been injected into 15-day-old 
rats to study their effects on glutamine 
synthetase activity. Animals of this age 
group were chosen because the highest rate 
of increase in the enzyme activity occurred 
in the succeeding days. Table I summarizes 
these findings. Puromycin produced the 
greatest inhibitory effect in vivo. With a 
dosage of 176 pg per gram of body weight, 
it inhibited almost completely glutamine 
synthetase in liver following two intraperi- 
toneal injections. On the other hand, adding 
puromycin to the reaction mixture to a 
final concentration of 390 I*g per milliliter 
did not decrease the enzyme activity of the 
liver. The result suggests that the decrease 
in the enzyme activity in vivo may represent 
a reduction in the amount of the enzyme in 
the tissue. The animals receiving the highest 
dosage of puromycin also lost body weight. 
Of the two amino acid analogs tested, 
nn-ethionine increased the enzyme activity 
in liver, whereas nn-p-fluorophenylalanine 
decreased it. The decrease in the enzyme 
activity was associated also with a loss of 
body weight. Injecting ethionine in the same 
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TABLE I 
EFFECT OF VARIOUS COMPOUNDS ON GLUTaMINE SYNTIIETASE ACTIVITY IN DEVELOPING R.~Ts 
Fifteen-day-old rats received single daily intraperitoneal injections of the compounds for 3 con- 
secutive days. Cortisol was given intramuscularly. The rats were killed one day after the last injection. 
Litter mates always served as the controls in each experiment. Exceptions are given in the accompany- 
ing footnotes. The enzyme activity is expressed as a percentage of the control value. The average 
values for liver and brain from a total of 18 control rats gave, respectively, 956 f 20.4 and 80.0 f 112.0 
(standard deviation) units per gram of tissue. 

















































2 0.3 pmole -0.4 96.6 f 4.6 
3 5M +0.3 163 f 10.3 
3 1 Pg -0.1 169 f 7.7 
2 2.1 pmoles +0.1 86.0 f 6.5 
3" 2.1 pmoles -0.2 67.3 f 5.9 
3d 3 fimoles 98.8 5 2.9 
3 10 @moles 
4 0.9 rmole -0.5 96.5 f 16.2 
2e 0.5 mg -2.8 141 Zt 4.0 
2 0.5 mg -4.1 117 * 0.0 
2’ 0.2 mg -8.3 122 f 17.0 
4 0.3 Imole -1.7 76.0 f 4.4 
4 0.4 ,umole -0.2 90.5 zt 9.2 
3r. P 1 rg -6.3 48.7 f 5.3 
2J 0.5l.G -7.0 73.1 f 6.2 
(0.0) (100.0) 
-2.9 5.4 f 0.4h 
-0.3 83.6 i 3.3 
-0.1 107 f 6.3 
-0.6 139 f 7.3 
-0.4 148 f 2.0 
-3.1 66.4 f 8.8 
-0.2 104 * 4.0 
(100.0) 
80.2 f 5.4 
111 f 4.8 
97.9 f 2.9 
97.1 f 6.0 
99.4 f 6.9 
104 f 4.5 
99.6 f 0.4 
97.0 f 3.2 
100 f 7.5 
107 f 9.6 
102 f 9.3 
106 f 5.3 
97.0 f 0.9 
78.0 f 6.0 
99.3 f 7.2 
110 f 8.0 
114 f 6.1 
107 zk 4.7 
103 f 1.0 
a The average difference in body weight between the treated and the control rats. 
b The experiment was terminated one day after the second injection, when the animals appeared 
very sick. On autopsy the gastrointestinal tract was yellow, and the abdominal cavity had a foul odor. 
c The animals received one additional (fourth) injection 4 hours before sacrifice. 
d Twenty-one-day-old rats weighing about 47 gm were used in this experiment which lasted 4 days. 
e The animals were killed 6 hours after the last injection. 
f Twenty-five-day-old male rats weighing about 65 gm were used. 
Q The experiment was terminated one day after the second injection, when two other animals had 
died, and one was dying. 
h The value following the + sign is the average deviation from the mean. 
dosage to adult male rats, however, did not concentration of 2.2 or 5.5 mM, respectively, 
increase the enzyme activity in liver. When neither compound affected the enzyme ac- 
ethionine or p-fluorophenylalanine was tivity of rat liver. 
added to the reaction mixture to a final Both cortisol and thyroxine caused a 
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significant increase in glutamine synthetase 
activity in infant rat liver. Injecting cortisol, 
however, in a similar dosage to adult rats 
did not result in an increase in the enzyme 
activity in liver. Thyroxine, when added to 
the reaction mixture to a final concentration 
of 11 pg per milliliter, showed no effect on 
the enzyme activity. 
The liver weight of infant rats receiving 
nn-ethionine, cortisol, or thyroxine was the 
same as that of the control rats. Hence, the 
increase in the enzyme activity in the liver 
of these injected rats can be attributed to 
an increase in the amount of the enzyme in 
the liver. 
Ammonium lactate decreased the en- 
zyme activity in liver. The dosage used was 
one fourth of LDsO (11). A further lowering 
of the enzyme activity occurred 4 hours 
after injecting one additional dose of the 
compound to the rat. 
nn-allo-&Hydroxylysine, which inhibited 
glutamine synthetase in vitro in a variety 
of tissues (9), did not affect the activity in 
vivo. Daily urine specimens from these 
rats were collected before and during the 
experimental period. With the method of 
Chinard (12) and a chromatographic pro- 
cedure (13)) about 40 % of the hydroxylysine 
injected was found in the urine in a 24-hour 
period. The relatively rapid excretion of the 
compound might account for its ineffective- 
ness in viva. 
Sodium glutamate exerted no effect on 
glutamine synthetase activity in liver. Glu- 
tamine, injected intraperitoneally into adult 
male rats in a dosage of 7 pmoles per gram 
of body weight twice daily for 5 consecutive 
days, did not change the enzyme activity 
in either the liver or the brain. 
Injecting the analogs of purines and 
pyrimidines gave varied effects on the liver 
enzyme. Deoxyadenosine, an inhibitor of 
DKA2 synthesis (14), produced no effect on 
the enzyme activity. But 5-fluorouracil, 
another inhibitor of DNA synthesis (15), 
increased it. The increase in the enzyme 
activity took place, while the animals were 
losing body weight from receiving the com- 
pound. The result expressed in either specific 
z Abbreviations: DNA, deoxyribonucleic acid; 
RNA, ribonucleic acid. 
activity or tissue activity shows a similar 
increase. Adding 5-fluorouracil, however, to 
the reaction mixture to a final concentration 
of 1.7 mg per milliliter had no effect on the 
enzyme activity. On the other hand, the 
enzyme activity decreased in the liver of 
rats receiving 8azaguanine. 
Recently, Reich et al. (16) have shown 
that actinomycin D inhibits RNA synthesis 
in mammalian cells. The compound was 
extremely toxic; a dosage of 1 pg per gram 
of body weight sufficed to kill the rat in 2 
days following two intraperitoneal injections. 
Actinomycin D also caused the animals to 
lose body weight. Glutamine synthetase 
activity dropped considerably in the liver of 
these rats. On the other hand, actinomycin D 
at a concentration of 3 pg per milliliter of 
the reaction mixture did not decrease the 
enzyme activity in vitro. 
The results in Table I also show that the 
enzyme in rat brain (cerebrum) has resisted 
most efforts to change its activity. When 
puromycin inhibited almost completely the 
enzyme in liver, it merely lowered the 
enzyme activity in brain by 20%. The 
amino acid analogs, the hormones, am- 
monium lactate, 5-fluorouracil, 8-azagua- 
nine, and actinomycin D failed to bring 
about a definite change in the brain enzyme 
despite their effect on the liver enzyme. The 
results, in general, emphasize an inertness 
of the brain enzyme and a responsiveness of 
the liver enzyme to metabolic alterations. 
BREAKDOWN OF GLUTAMINE SYNTHETASE 
Puromycin inhibited in viva the synthesis 
of protein from amino acids in mammalian 
liver (17). This observation taken in con- 
junction with the inhibition by this com- 
pound of glutamine synthetase in rat liver 
made it possible to study the breakdown of 
this enzyme in rat tissues. On the assumption 
that the dosage of puromycin injected into 
the rat was sufficient to block completely 
the synthesis of the enzyme, the decrease 
in the enzyme activity with time would 
indicate the rate of breakdown of the en- 
zyme. Figure 3 shows the results of such an 
approach. The fall in glutamine synthetase 
activity during the multiple injections of 
puromycin into 24-day-old rats has been 
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followed in the four organs possessing the 
enzyme activity, namely, the brain, liver, 
kidney, and testis (9). Consistent with the 
results shown in Table I, the brain enzyme 
maintained its normal activity throughout 
the experimental period. The kidney en- 
zyme exhibited a very slight decline only. 
The enzyme activity in liver, though fluc- 
tuating, showed a definite fall. Thus, if a 
line is drawn in between these points (Fig. 3) 
and extrapolated, it would indicate that, in 
about 14 hours, the enzyme activity would 
have been reduced to one half of its original 
value at hour zero. The result calculated 
here can be approximate only because of the 
fluctuation of the enzyme activity and the 
assumption that the decline proceeded 
linearly. A similar estimate yielded about 
7.5 hours for the enzyme in testis. Hence, the 
0; 
TIME IN HOURS 
FIG. 3. Rates of breakdown of glutamine syn- 
thetase in rat liver (O-O), kidney (O-O), 
brain (X--X), and testis (A---A). Twenty- 
four-day-old male rats weighing about 60 gm 
received 3 mg of puromycin dihydrochloride (pH 
adjusted) in each intraperitoneal injection given 
at 0,2,4, and 6 hours, and were killed at 1,3,5, and 
7 hours after the first injections. Each point repre- 
sents the average from 4 to 7 rats. The average 
deviations from the mean values at 0, 1,3, 5, and 7 
hours for the liver were 26.0, 9.2, 8.4, 2.7, and 7.2, 
respectively; those for the testis were 1.0, 1.8, 1.7, 
1.7, and 1.0, respectively. 
turnover rates of the enzyme in the liver 
and testis were very much different. The 
very slight decrease in the enzyme activity 
observed with the brain and kidney may 
result from very low turnover rates of the 
enzyme in these tissues, or it may indicate 
that these tissues are not readily permeable 
to puromycin. 
The per cent loss of the enzyme activity 
in liver 48 hours after injecting the highest 
dosage of puromycin into 15-day-old rats, 
shown in Table I, approximated a rate of 
loss of one half the enzyme activity in every 
12 hours. This rate was close to the rate of 
breakdown calculated from the results ob- 
tained with 24-day-old rats, shown in Fig. 3. 
Perhaps, the rates of breakdown of the 
enzyme in rats of different age groups vary 
little; the changes seen in Fig. 1 may actually 
represent the varied rates of synthesis of the 
enzyme with age. 
DISCUSSION 
The present study shows that the activity 
of glutamine synthetase in vivo can be 
controlled by a number of compounds with 
varied metabohc properties. Since these 
compounds exerted no effect on the enzyme 
activity in vitro, the results suggest that the 
change in the activity in vivo may represent 
a corresponding change in the amount of 
the enzyme in the tissue. 
Three kinds of metabolic alterations ap- 
pear to affect the synthesis of the enzyme: 
(a) alterations in protein synthesis, (b) 
alterations in RNA synthesis, and (c) altera- 
tions in DNA synthesis. To the first kind 
belongs the effect of puromycin and of 
p-A uorophenylalanine. Both compounds in- 
hibit protein synthesis in vivo. Their ad- 
ministration has caused loss of body weight 
in the developing rat. Cohen et al. (18) have 
suggested the synthesis of inactive enzyme 
by yeast cells in the presence of p-fluoro- 
phenylalanine. This possibility may also be 
considered in the rat liver. 
Sokoloff et al. (19, 20) have shown that 
thyroxine stimulates amino acid incorpora- 
tion into protein. Metzenberg et al. (21) 
have presented evidence showing the induc- 
tion by thyroxine of de novo synthesis of 
carbamyl phosphate synthetase in tadpoles. 
These two observations may serve to ex- 
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plain the elevation of glutamine synthetme 
activity by thyroxine in the developing rat. 
Cortisone administration stimulates the 
incorporation of precursors into liver RNA 
in vivo (22). The cortisol-mediated increase 
in glutamine synthetase activity appears to 
result from an increase in the de novo syn- 
thesis of RNA. This mediation, however, 
seems to be limited to the synthesis of the 
enzyme in the developing rat, inasmuch as 
cortisol becomes ineffective in raising the 
enzyme activity in the adult rat where the 
maximal level of the enzyme has been 
reached. The dependence of the develop- 
mental increase in glutamine synthetase on 
RNA synthesis is also evident from the 
inhibitory effect of actinomycin D on the 
enzyme activity. Recently, Greengard et al. 
(23), and Nemeth (24) have demonstrated 
the relation of RNA synthesis to the forma- 
tion of certain enzymes during development. 
In contrast to inhibitors of protein syn- 
thesis or of RNA synthesis, which inhibited 
glutamine synthetase, inhibitors of DNA 
synthesis did not decrease the synthetase 
activity; some of them increased it. Like 
cortisol, ethionine showed its stimulatory 
effect on the liver enzyme of developing rats 
but not that of adult rats. But the mecha- 
nism underlying the stimulation by ethionine 
probably resembles that by 5fluorouraci1, 
since, like 5-fluorouracil, ethionine also in- 
hibits DNA synthesis in vivo (25). The 
relation of DNA synthesis to the formation 
of glutamine synthetase will be considered 
further in the following paper. 
The dosage of puromycin used to block the 
synthesis of glutamine synthetase was about 
62% of that used by Nemeth (24) to obtain 
the turnover rate of tryptophan pyrrolase. 
The rate of breakdown of the synthetase 
estimated in this study should be considered 
approximate, since how completely puromy- 
tin blocked the synthesis has not been 
ascertained. 
Glutamine synthetase is not repressible 
by glutamine in the rat, although repression 
by glutamine of glutamyl transferase in 
mammalian cell cultures has been reported 
(26). The synthetase is also not inducible 
by glutamate or ammonia. Conversely, in- 
jecting ammonia lowered the enzyme ac- 
tivity, although Duda and Handler (27) 
showed that, within 30 minutes, 80 % of the 
intravenously administered ammonia was 
converted to glut,amine in the rat. 
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